NCT02685592View on ClinicalTrials.gov

Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Lentigo Maligna
Interventions
DRUG

5-aminolevulinic acid nanoemulsion

A 1 millimeter thick layer of 5-aminolevulinic acid nanoemulsion light sensitizing gel is applied on the skin and let to absorb 3 hours before illumination.

Trial Locations (1)

Unknown

Päijät-Häme Central Hospital, Lahti

All Listed Sponsors
collaborator

Huslab, Finland

UNKNOWN

collaborator

Tampere University

OTHER

lead

Joint Authority for Päijät-Häme Social and Health Care

OTHER

NCT02685592 - Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream | Biotech Hunter | Biotech Hunter